AAPL302.19-31.24 (-9.37%) ▼|ABBV251.85-5.57 (-2.16%) ▼|ABT105.92+0.31 (+0.29%) ▲|ACN165.96+2.67 (+1.64%) ▲|ADBE249.85+1.95 (+0.78%) ▲|AMAT516.23+14.46 (+2.88%) ▲|AMD487.76+2.37 (+0.49%) ▲|AMGN386.01-1.63 (-0.42%) ▼|AMT172.47-2.00 (-1.14%) ▼|AMZN270.84+35.34 (+15.01%) ▲|AVGO388.81+0.97 (+0.25%) ▲|AXP337.59+0.07 (+0.02%) ▲|BA216.33-4.58 (-2.07%) ▼|BAC62.06+0.33 (+0.53%) ▲|BKNG194.71+1.47 (+0.76%) ▲|BLK1,090.80-7.57 (-0.69%) ▼|BMY65.16+0.30 (+0.46%) ▲|BNY156.56+0.48 (+0.31%) ▲|BRK-B512.14+2.46 (+0.48%) ▲|C133.05+0.73 (+0.55%) ▲|CAT818.87+9.73 (+1.20%) ▲|CL91.06-0.55 (-0.60%) ▼|CMCSA24.13+0.46 (+1.92%) ▲|COF207.80-2.34 (-1.11%) ▼|COP119.95+0.92 (+0.77%) ▲|COST953.84-0.33 (-0.03%) ▼|CRM183.35+2.64 (+1.46%) ▲|CSCO115.90+2.34 (+2.06%) ▲|CVS105.15-0.08 (-0.07%) ▼|CVX196.37+4.06 (+2.11%) ▲|DE594.82-4.66 (-0.78%) ▼|DHR196.15-0.03 (-0.01%) ▼|DIS96.33+0.17 (+0.18%) ▲|DUK125.50-0.77 (-0.61%) ▼|EMR150.44+1.80 (+1.21%) ▲|FDX308.43-0.12 (-0.04%) ▼|GD383.01+0.81 (+0.21%) ▲|GE361.57+6.53 (+1.84%) ▲|GEV992.96+10.98 (+1.12%) ▲|GILD130.79-0.49 (-0.37%) ▼|GM88.95+0.55 (+0.62%) ▲|GOOG356.04+22.36 (+6.70%) ▲|GOOGL356.04+22.38 (+6.71%) ▲|GS1,021.58-3.28 (-0.32%) ▼|HD332.20-1.15 (-0.35%) ▼|HON245.10+3.19 (+1.32%) ▲|IBM221.40-0.34 (-0.15%) ▼|INTC92.78+1.65 (+1.81%) ▲|INTU316.32+0.82 (+0.26%) ▲|ISRG354.26+1.29 (+0.36%) ▲|JNJ258.08+2.26 (+0.88%) ▲|JPM353.00+2.15 (+0.61%) ▲|KO87.63-0.87 (-0.98%) ▼|LIN477.04-31.61 (-6.21%) ▼|LLY1,144.00-10.97 (-0.95%) ▼|LMT580.93+6.82 (+1.19%) ▲|LOW208.49-1.59 (-0.76%) ▼|LRCX301.14+3.42 (+1.15%) ▲|MA572.84-4.51 (-0.78%) ▼|MCD270.85+2.41 (+0.90%) ▲|MDLZ62.36-0.73 (-1.15%) ▼|MDT85.71+0.00 (+0.00%) ▲|META549.95+10.92 (+2.02%) ▲|MMM176.09+0.02 (+0.01%) ▲|MO68.70+0.76 (+1.12%) ▲|MRK130.55+0.76 (+0.59%) ▲|MS210.62+1.71 (+0.82%) ▲|MSFT463.02+11.92 (+2.64%) ▲|MU836.79-37.87 (-4.33%) ▼|NEE87.77-0.16 (-0.18%) ▼|NFLX71.67-1.50 (-2.05%) ▼|NKE41.85-0.44 (-1.04%) ▼|NOW111.16+1.09 (+0.99%) ▲|NVDA198.73+3.69 (+1.89%) ▲|ORCL128.89+1.33 (+1.04%) ▲|PEP140.05-0.16 (-0.11%) ▼|PFE25.13+0.22 (+0.88%) ▲|PG144.02+0.06 (+0.04%) ▲|PLTR122.20-0.06 (-0.05%) ▼|PM191.39-0.61 (-0.32%) ▼|QCOM148.40-3.20 (-2.11%) ▼|RTX215.26+0.88 (+0.41%) ▲|SBUX105.73-0.12 (-0.11%) ▼|SCHW105.15+0.82 (+0.79%) ▲|SO94.79+0.45 (+0.48%) ▲|SPG230.89+0.45 (+0.20%) ▲|T23.22+0.01 (+0.04%) ▲|TMO573.76-3.01 (-0.52%) ▼|TMUS170.99-2.35 (-1.36%) ▼|TSLA311.02+2.17 (+0.70%) ▲|TXN276.84-1.92 (-0.69%) ▼|UBER70.01-0.36 (-0.51%) ▼|UNH418.57-2.91 (-0.69%) ▼|UNP292.01+2.55 (+0.88%) ▲|UPS104.14-1.13 (-1.07%) ▼|USB62.98+0.08 (+0.13%) ▲|V366.29+0.02 (+0.01%) ▲|VZ46.68+0.57 (+1.24%) ▲|WFC86.25+0.82 (+0.95%) ▲|WMT111.39+0.29 (+0.26%) ▲|XOM154.58-2.39 (-1.52%) ▼|AAPL302.19-31.24 (-9.37%) ▼|ABBV251.85-5.57 (-2.16%) ▼|ABT105.92+0.31 (+0.29%) ▲|ACN165.96+2.67 (+1.64%) ▲|ADBE249.85+1.95 (+0.78%) ▲|AMAT516.23+14.46 (+2.88%) ▲|AMD487.76+2.37 (+0.49%) ▲|AMGN386.01-1.63 (-0.42%) ▼|AMT172.47-2.00 (-1.14%) ▼|AMZN270.84+35.34 (+15.01%) ▲|AVGO388.81+0.97 (+0.25%) ▲|AXP337.59+0.07 (+0.02%) ▲|BA216.33-4.58 (-2.07%) ▼|BAC62.06+0.33 (+0.53%) ▲|BKNG194.71+1.47 (+0.76%) ▲|BLK1,090.80-7.57 (-0.69%) ▼|BMY65.16+0.30 (+0.46%) ▲|BNY156.56+0.48 (+0.31%) ▲|BRK-B512.14+2.46 (+0.48%) ▲|C133.05+0.73 (+0.55%) ▲|CAT818.87+9.73 (+1.20%) ▲|CL91.06-0.55 (-0.60%) ▼|CMCSA24.13+0.46 (+1.92%) ▲|COF207.80-2.34 (-1.11%) ▼|COP119.95+0.92 (+0.77%) ▲|COST953.84-0.33 (-0.03%) ▼|CRM183.35+2.64 (+1.46%) ▲|CSCO115.90+2.34 (+2.06%) ▲|CVS105.15-0.08 (-0.07%) ▼|CVX196.37+4.06 (+2.11%) ▲|DE594.82-4.66 (-0.78%) ▼|DHR196.15-0.03 (-0.01%) ▼|DIS96.33+0.17 (+0.18%) ▲|DUK125.50-0.77 (-0.61%) ▼|EMR150.44+1.80 (+1.21%) ▲|FDX308.43-0.12 (-0.04%) ▼|GD383.01+0.81 (+0.21%) ▲|GE361.57+6.53 (+1.84%) ▲|GEV992.96+10.98 (+1.12%) ▲|GILD130.79-0.49 (-0.37%) ▼|GM88.95+0.55 (+0.62%) ▲|GOOG356.04+22.36 (+6.70%) ▲|GOOGL356.04+22.38 (+6.71%) ▲|GS1,021.58-3.28 (-0.32%) ▼|HD332.20-1.15 (-0.35%) ▼|HON245.10+3.19 (+1.32%) ▲|IBM221.40-0.34 (-0.15%) ▼|INTC92.78+1.65 (+1.81%) ▲|INTU316.32+0.82 (+0.26%) ▲|ISRG354.26+1.29 (+0.36%) ▲|JNJ258.08+2.26 (+0.88%) ▲|JPM353.00+2.15 (+0.61%) ▲|KO87.63-0.87 (-0.98%) ▼|LIN477.04-31.61 (-6.21%) ▼|LLY1,144.00-10.97 (-0.95%) ▼|LMT580.93+6.82 (+1.19%) ▲|LOW208.49-1.59 (-0.76%) ▼|LRCX301.14+3.42 (+1.15%) ▲|MA572.84-4.51 (-0.78%) ▼|MCD270.85+2.41 (+0.90%) ▲|MDLZ62.36-0.73 (-1.15%) ▼|MDT85.71+0.00 (+0.00%) ▲|META549.95+10.92 (+2.02%) ▲|MMM176.09+0.02 (+0.01%) ▲|MO68.70+0.76 (+1.12%) ▲|MRK130.55+0.76 (+0.59%) ▲|MS210.62+1.71 (+0.82%) ▲|MSFT463.02+11.92 (+2.64%) ▲|MU836.79-37.87 (-4.33%) ▼|NEE87.77-0.16 (-0.18%) ▼|NFLX71.67-1.50 (-2.05%) ▼|NKE41.85-0.44 (-1.04%) ▼|NOW111.16+1.09 (+0.99%) ▲|NVDA198.73+3.69 (+1.89%) ▲|ORCL128.89+1.33 (+1.04%) ▲|PEP140.05-0.16 (-0.11%) ▼|PFE25.13+0.22 (+0.88%) ▲|PG144.02+0.06 (+0.04%) ▲|PLTR122.20-0.06 (-0.05%) ▼|PM191.39-0.61 (-0.32%) ▼|QCOM148.40-3.20 (-2.11%) ▼|RTX215.26+0.88 (+0.41%) ▲|SBUX105.73-0.12 (-0.11%) ▼|SCHW105.15+0.82 (+0.79%) ▲|SO94.79+0.45 (+0.48%) ▲|SPG230.89+0.45 (+0.20%) ▲|T23.22+0.01 (+0.04%) ▲|TMO573.76-3.01 (-0.52%) ▼|TMUS170.99-2.35 (-1.36%) ▼|TSLA311.02+2.17 (+0.70%) ▲|TXN276.84-1.92 (-0.69%) ▼|UBER70.01-0.36 (-0.51%) ▼|UNH418.57-2.91 (-0.69%) ▼|UNP292.01+2.55 (+0.88%) ▲|UPS104.14-1.13 (-1.07%) ▼|USB62.98+0.08 (+0.13%) ▲|V366.29+0.02 (+0.01%) ▲|VZ46.68+0.57 (+1.24%) ▲|WFC86.25+0.82 (+0.95%) ▲|WMT111.39+0.29 (+0.26%) ▲|XOM154.58-2.39 (-1.52%) ▼|
29.8 C
New York
Friday, July 31, 2026

Tag: common

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Via Transportation, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VIA

NEW YORK, June 27, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Via Transportation, Inc. (NYSE: VIA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Via’s initial public offering (the “IPO” or “Offering”) of the important August 10, 2026 lead plaintiff deadline.

ThinkCareBelieve: Week 75 of the Trump 2.0 Administration

Week 75 began on a day honoring our love for fathers, and it ended with a massive celebration of a country started by our fighting forefathers!

TBoostExperts.com Announces Availability of 2026 Consumer Report on Testosterone Booster Supplements and Men’s Health Supplement Evaluation

New report provides an educational framework for reviewing testosterone booster supplements, ingredient transparency, supplement labels, consumer safety considerations, and responsible product research.
New report provides an educational framework for reviewing testosterone booster supplements, ingredient transparency, supplement labels, consumer safety considerations, and responsible product research.

Taiwan Pedaling Towards EUROBIKE 2026 with CHC Innovations and Sustainability Achievements

FRANKFURT, Germany, June 27, 2026 /PRNewswire/ -- At EUROBIKE 2026, the Cycling & Health Tech Industry R&D Center (CHC), supported by the Ministry of...

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PicS N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PICS

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of PicS N.V. (NASDAQ: PICS) pursuant and/or traceable to PicS N.V.’s January 30, 2026 initial public offering (the “IPO”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2026.

Vietnam Tech Summit 2026 to Bring AI Leaders, Founders, Investors, and Vietnamese Tech Talent to Silicon Valley

Vietnam Tech Summit 2026 brings Vietnamese tech talent to Silicon Valley for AI programming, company visits, startup showcases, and networking.

ROSEN, A TOP RANKED LAW FIRM, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”), of the important August 4, 2026 lead plaintiff deadline.

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering

Persistent announces the intention to launch a voluntary public takeover offer for all outstanding Nagarro shares at EUR 81 per shareAll-cash offer represents a...

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Black Rock Coffee Bar, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action –...

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Black Rock Coffee Bar, Inc. (NASDAQ: BRCB): (i) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Black Rock Coffee’s September 2025 initial public offering (“IPO”); and/or (ii) securities between September 12, 2025 and May 12, 2026, both dates inclusive (the “Class Period”), of the important August 17, 2026 lead plaintiff deadline.

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or "Decoy"), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new...

ROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WGS

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August 3, 2026 lead plaintiff deadline.

Texas Business Court Grants Neugebauer’s Motion for Expedited Discovery in Lawsuit filed by Fermi Seeking to Block Shareholder Accountability

After losing in federal court, Fermi Board pivots to Texas Business Court who grants Toby Neugebauer's motion for expedited discovery pertaining to Fermi Board's...

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

LIKMEZ® (ATI-1501) commercial momentum building in U.S. market

US$40 million NIAID award supporting VXV-01 advancement through Phase 1

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCommon